Technology | June 22, 2015

ScanMed Introduces Non-Invasive Procure Prostate/Pelvic MRI Coil for Diagnosing Prostate Cancer

Device offers higher image quality, reducing high rates of false positives

ScanMed, ProCure, prostate/pelvic MRI coil, prostate cancer

June 22, 2015 - ScanMed announced the introduction of the non-invasive, wearable ProCure prostate/pelvic magnetic resonance imaging (MRI) coil to aid in diagnosing prostate cancer

According to the National Cancer Institute, prostate cancer is the most common cancer (1 of 6 men) inflicting men in the United States, after skin cancer. It is the second leading cause of death from cancer in men.

Men with elevated prostate-specific antigen (PSA) will often get a blind biopsy and are given a clean ill of health, even though such biopsies are reported to yield between 50 and 90 percent false negatives, meaning that the man did have cancer and it went undetected. After a cancer is left to grow for too long, then options are very few in terms of treatment - either complete removal of the prostate (prostatectomy) or thermal ablation of the entire organ.

The ProCure coil was born from evaluation of the current MRI tools available - non-dedicated antennae and endo-rectal coils that produced inadequate image quality or great reluctance or refusal of use, respectively. ProCure is a dedicated, diaper-like MRI coil which positions multiple antennae elements as close as possible to the target anatomies (the prostate and reproductive organs) regardless of patient size. The coil also allows for biopsy should a radiologist deem that a detected lesion warrants laboratory validation.

For more information: www.scanmed.com

Related Content

Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Indian Man Killed in MRI Accident. MRI magnet safety is key, the magnet is always on.
News | Magnetic Resonance Imaging (MRI) | January 30, 2018 | Jeff Zagoudis, Associate Editor
Investigations are underway at a hospital in Mumbai, India, after a man was killed when he was sucked into a magnetic...
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Approval for Pediatric MRI
News | Contrast Media | January 30, 2018
Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S. Food and Drug...
Overlay Init